Mettler-Toledo International Inc. (MTD) Director Sells $1,563,150.00 in Stock

Mettler-Toledo International Inc. (NYSE:MTD) Director Robert F. Spoerry sold 2,500 shares of the company’s stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $625.26, for a total value of $1,563,150.00. Following the completion of the transaction, the director now owns 7,295 shares of the company’s stock, valued at approximately $4,561,271.70. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Mettler-Toledo International Inc. (NYSE MTD) opened at $634.37 on Friday. The company has a debt-to-equity ratio of 1.75, a quick ratio of 1.09 and a current ratio of 1.46. The firm has a market capitalization of $16,230.00, a price-to-earnings ratio of 37.34, a PEG ratio of 2.62 and a beta of 1.08. Mettler-Toledo International Inc. has a 12 month low of $464.30 and a 12 month high of $697.26.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, February 8th. The medical instruments supplier reported $5.97 earnings per share for the quarter, topping the consensus estimate of $5.93 by $0.04. The company had revenue of $778.03 million during the quarter, compared to the consensus estimate of $764.26 million. Mettler-Toledo International had a return on equity of 94.54% and a net margin of 13.80%. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $5.28 EPS. research analysts forecast that Mettler-Toledo International Inc. will post 20.15 earnings per share for the current fiscal year.

Several hedge funds have recently bought and sold shares of the company. BlackRock Inc. grew its stake in shares of Mettler-Toledo International by 2.3% during the 4th quarter. BlackRock Inc. now owns 1,847,591 shares of the medical instruments supplier’s stock worth $1,144,617,000 after acquiring an additional 41,344 shares during the period. Goldman Sachs Group Inc. boosted its stake in Mettler-Toledo International by 0.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 482,730 shares of the medical instruments supplier’s stock worth $299,061,000 after purchasing an additional 3,876 shares during the period. Russell Investments Group Ltd. boosted its stake in Mettler-Toledo International by 2.5% in the 4th quarter. Russell Investments Group Ltd. now owns 328,763 shares of the medical instruments supplier’s stock worth $204,608,000 after purchasing an additional 7,996 shares during the period. Geode Capital Management LLC boosted its stake in Mettler-Toledo International by 3.5% in the 4th quarter. Geode Capital Management LLC now owns 305,818 shares of the medical instruments supplier’s stock worth $189,106,000 after purchasing an additional 10,258 shares during the period. Finally, Janus Henderson Group PLC boosted its stake in Mettler-Toledo International by 20.2% in the 3rd quarter. Janus Henderson Group PLC now owns 243,920 shares of the medical instruments supplier’s stock worth $152,732,000 after purchasing an additional 40,993 shares during the period. Institutional investors own 91.79% of the company’s stock.

A number of brokerages have issued reports on MTD. Morgan Stanley upped their price objective on Mettler-Toledo International from $550.00 to $580.00 and gave the company an “equal weight” rating in a research note on Friday, February 9th. Citigroup upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and upped their price objective for the company from $685.00 to $692.00 in a research note on Friday, February 9th. Robert W. Baird reduced their price objective on Mettler-Toledo International from $675.00 to $630.00 and set a “neutral” rating for the company in a research note on Friday, February 9th. Evercore ISI began coverage on Mettler-Toledo International in a research note on Wednesday, January 3rd. They issued an “in-line” rating and a $625.00 price objective for the company. Finally, Zacks Investment Research downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Tuesday, November 7th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Mettler-Toledo International currently has an average rating of “Buy” and a consensus price target of $651.44.

WARNING: This report was published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://www.thelincolnianonline.com/2018/02/18/mettler-toledo-international-inc-mtd-director-sells-1563150-00-in-stock.html.

About Mettler-Toledo International

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Insider Buying and Selling by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply